IFN-γ-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis

Journal of Immunology

Volumn 163, Issue 10, 1999, Pages 5686-5692

  Keane, Michael P ^a   Belperio, John A ^a   Arenberg, Douglas A ^a   Burdick, Marie D ^a   Xu, Zuo J ^a   Xue, Ying Y ^a   Strieter, Robert M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHEMOKINE; GAMMA INTERFERON;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HISTOPATHOLOGY; LUNG FIBROSIS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BIOLOGICAL ASSAY; BLEOMYCIN; CELL DIVISION; CELLS, CULTURED; CHEMOKINES, CXC; CORNEAL NEOVASCULARIZATION; FEMALE; FIBROBLASTS; INTERFERON TYPE II; LUNG; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; NEOVASCULARIZATION, PATHOLOGIC; PULMONARY FIBROSIS; RATS; RATS, LONG-EVANS;

EID: 0033571117     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Coultas, D. B., R. E. Zumwalt, W. C. Black, and R. E. Sobonya. 1994. The epidemiology of interstitial lung diseases. Am. J. Respir. Crit. Care Med. 150:967.
2. du Bois, R. M. 1997. Diffuse lung disease: a view for the future. Sarcoidosis Vasc. Diffuse Lung Dis. 14:23.
3. Turner-Warwick, M. 1963. Precapillary systemic-pulmonary anastomoses. Thorax 18:225.
4. Peao, M. N. D., A. P. Aguas, C. M. DeSa, and N. R. Grande. 1994. Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin. Anat. Rec. 238:57.
5. Strieter, R. M., P. J. Polverini, S. L. Kunkel, D. A. Arenberg, M. D. Burdick, J. Kasper, J. Dzuiba, J. Van Damme, A. Walz, D. Marriott, et al. 1995. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270:27348.
6. Koch, A. E., P. J. Polverini, S. L. Kunkel, L. A. Harlow, L. A. DiPietro, V. M. Elner, S. G. Elner, and R. M. Strieter. 1992. Interleukin-8 (IL-8) as a macrophage-derived mediator of angiogenesis. Science 258:1798.
7. Hu, D. E., Y. Hori, and T. P. D. Fan. 1993. Interleukin-8 stimulates angiogenesis in rats. Inflammation 17:135.
8. Strieter, R. M., S. L. Kunkel, V. M. Elner, C. L. Martonyl, A. E. Koch, P. J. Polverini, and S. G. Elner. 1992. Interleukin-8: a corneal factor that induces neovascularization. Am J. Pathol. 141:1279.
9. Strieter, R. M., S. L. Kunkel, D. A. Arenberg, M. D. Burdick, and P. J. Polverini. 1995. Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem. Biophys. Res. Commun. 210:51.
10. Arenberg, D. A., S. L. Kunkel, P. J. Polverini, S. B. Morris, M. D. Burdick, M. Glass, D. T. Taub, M. D. Iannetoni, R. I. Whyte, and R. M. Strieter. 1996. Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J. Exp. Med. 184:981.
11. Keane, M. P., D. A. Arenberg, J. P. R. Lynch, R. I. Whyte, M. D. Iannettoni, M. D. Burdick, C. A. Wilke, S. B. Morris, M. C. Glass, B. DiGiovine, et al. 1997. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J. Immunol. 159:1437.
12. Keane, M. P., J. A. Belperio, T. A. Moore, B. B. Moore, D. A. Arenberg, R. E. Smith, M. D. Burdick, S. L. Kunkel, and R. M. Strieter. 1999. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J. Immunol. 162:5511.
13. Arenberg, D. A., S. L. Kunkel, P. J. Polverini, M. Glass, M. D. Burdick, and R. M. Strieter. 1996. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Invest. 97:2792.
14. Smith, R. E., R. M. Strieter, S. H. Phan, N. W. Lukacs, G. B. Huffnagle, C. A. Wilke, M. D. Burdick, P. Lincoln, H. Evanoff, and S. L. Kunkel. 1994. Production and function of murine macrophage inflammatory protein-1a in bleomycin-induced lung injury. J. Immunol. 153:4704.
15. Smith, D. R., P. J. Polverini, S. L. Kunkel, M. B. Orringer, R. I. Whyte, M. D. Burdick, C. A. Wilke, and R. M. Strieter. 1994. IL-8 mediated angiogenesis in human bronchogenic carcinoma. J. Exp. Med. 179:1409.
16. Ashcroft, T., J. M. Simpson, and V. Timbrell. 1988. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41:467.
17. + T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J. Leukocyte Biol. 55:35.
18. Adamson, I. Y., and D. H. Bowden. 1974. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am. J. Pathol. 77:185.
19. Chandler, D. B. 1990. Possible mechanisms of bleomycin-induced fibrosis. Clin. Chest Med. 11:21.
20. Bowden, D. H. 1984. Unraveling pulmonary fibrosis: the bleomycin model. Lab. Invest. 50:487.
21. Bedrossian, C. M. W., S. D. Grennberg, D. H. Yawn, and R. M. O'Neil. 1977. Experimentally induced bleomycin sulfate pulmonary toxicity. Arch. Pathol. Lab. Med. 101:248.
22. Aso, Y., and Y. Yoneda. 1976. Morphological and biochemical study of pulmonary changes induced by bleomycin in mice. Lab. Invest. 35:558.
23. Schrier, D. J., R. G. Kunkel, and S. H. Phan. 1983. The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am. Rev. Respir. Dis. 127:63.
24. Henke, C., V. Fiegel, M. Peterson, M. Wick, D. Knighton, J. McCarthy, and P. Bitterman. 1991. Identification and partial characterization of angiogenesis bioactivity in the lower respiratory tract after acute lung injury. J. Clin. Invest. 88:1386.
25. Marinelli, W. A., C. A. Henke, K. R. Harmon, M. I. Hertz, and P. B. Bitterman. 1990. Mechanisms of alveolar fibrosis after acute lung injury. Clin. Chest Med. 11:657.
26. Piguet, P. F., C. Vesin, G. E. Grau, and R. C. Thompson. 1993. Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine 5:57.
27. Piguet, P. F., C. Vesin, and F. Thomas. 1995. Bombesin down modulates pulmonary fibrosis elicited in mice by bleomycin. Exp. Lung Res. 21:227.
28. Gunijeyalakshmi, G., and S. N. Giri. 1995. Molecular mechanisms of antifibrotic effect of interferon γ in bleomycin-mouse model of lung fibrosis: downregulation of TGF-β and procollagen I and III gene expression. Exp. Lung Res. 21:791.
29. Luster, A. D., R. D. Cardiff, J. A. MacLean, K. Crowe, and R. D. Granstein. 1998. Delayed wound healing and disorganized neovascularization in transgenic mice expressing the IP-10 chemokine. Proc. Assoc. Am. Physicians 110:183.
30. Koch, A. E., P. J. Polverini, and S. J. Leibovich. 1986. Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arthritis Rheum. 29:471.
31. Nickoloff, B. J., R. S. Mitra, J. Varani, V. M. Dixit, and P. J. Polverini. 1994. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes. Am. J. Pathol. 144:820.
32. Koch, A. E., S. L. Kunkel, J. L. Burrows, H. L. Evanoff, G. K. Haines, R. M. Pope, and R. M. Strieter. 1991. The synovial tissue macrophage as a source of the chemotactic cytokine interleukin-8. J. Immunol. 147:2187.
33. Storgard, C. M., D. G. Stupack, A. Jonczyk, S. L. Goodman, R. I. Fox, and D. A. Cheresh. 1999. Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist. J. Clin. Invest. 103:47.
34. Kaplan, G., A. D. Luster, G. Hancock, and Z. A. Cohn. 1987. The expression of a γ interferon-induced protein (IP-10) in delayed immune responses in human skin. J. Exp. Med. 166:1098.
35. Boorsma, D. M., P. de Haan, R. Willemze, and T. J. Stoof. 1994. Human growth factor (huGRO), interleukin-8 (IL-8) and interferon-γ-inducible protein (γ-IP-10) gene expression in cultured normal human keratinocytes. Arch. Dermatol. Res. 286:471.
36. Gomez-Chiarri, M., T. A. Hamilton, J. Egido, and S. N. Emancipator. 1993. Expression of IP-10, a lipopolysaccharide- and interferon-[gamma-]inducible protein, in murine mesangial cells in culture. Am. J. Pathol. 142:433.
37. Gattass, C. R., L. B. King, A. D. Luster, and J. D. Ashwell. 1994. Constitutive expression of interferon γ-inducible protein 10 in lymphoid organs and inducible expression in T cells and thymocytes. J. Exp. Med. 179:1373.
38. Farber, J. M. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukocyte Biol. 61:246.
39. Stout, A. J., I. Gresser, and D. Thompson. 1993. Inhibition of wound healing in mice by local interferon α/β injection. Int. J. Exp. Pathol. 74:79.
40. Hyde, D. M., T. S. Henderson, S. N. Giri, N. K. Tyler, and M. Y. Stovall. 1988. Effect of murine γ interferon on the cellular responses to bleomycin in mice. Exp. Lung Res. 14:687.
41. Yao, L., C. Sgadari, K. Furuke, E. T. Bloom, J. Teruya-Feldstein, and G. Tosato. 1999. Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12. Blood 93:1612.
42. Kanegane, C., C. Sgadari, H. Kanegane, J. Teruya-Feldstein, L. Yao, G. Gupta, J. M. Farber, F. Liao, L. Liu, and G. Tosato. 1998. Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12. J. Leukocyte Biol. 64:384.
43. Schrier, D. J., S. H. Phan, and B. M. McGarry. 1983. The effects of the nude (nu/nu) mutation on bleomycin-induced pulmonary fibrosis: a biochemical evaluation. Am. Rev. Respir. Dis. 127:614.
44. Piguet, P. F., M. A. Collart, G. E. Grau, Y. Kapanci, and P. Vassalli. 1989. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 170:655.
45. Helene, M., V. Lake-Bullock, J. Zhu, H. Hao, D. A. Cohen, and A. M. Kaplan. 1999. T cell independence of bleomycin-induced pulmonary fibrosis. J. Leukocyte Biol. 65:187.
46. Clark, R. A. 1985. Cutaneous tissue repair: basic biologic considerations. I. Am. Acad. Dermatol. 13:701.
47. Clark, R. A. 1993. Basics of cutaneous wound repair. J. Dermatol. Surg. Oncol. 19:693.
48. Clark, R. A. 1993. Regulation of fibroplasia in cutaneous wound repair. Am. J. Med. Sci. 306:42.